In this study, we demonstrate the presence of an extensive immunosuppressive microenvironment in GBM, but not in grade II and III gliomas, due to the presence of blood-derived macrophages, expressing PD-L1, and of T cells showing markers associated to impaired T cell function. The gene discussed is CD274; the disease is glioblastoma.